CoreAge Rx vs NativeMed
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and NativeMed head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
NativeMed
FDA warning letter, June 2026 — issued to NativeMed LLC dba NativeMed. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 62 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make NativeMed a bad call — it's best for readers comparing prepaid compounded injections with monthly renewal who confirm the selected supply and administrative cancellation fee. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | NativeMed |
|---|---|---|
| Brief Score | 94/100 (A) | 62/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $447 upfront for three months Advertised equivalent $149/month. Separate monthly choice: $159 first month, then $179; compounded injection and shipping described. Selected quantity and care inclusions need confirmation. Early refund request requires action within twenty-four hours before shipment and deducts an unspecified administrative fee. Full price detailsCompounded semaglutide injection offered; complete selected-prescription quote unknown; three-month plan $447 upfront ($149/month equivalent), or monthly $179 after $159 first month |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $549 upfront for three months Advertised equivalent $183/month. Separate monthly choice: $199 first month, then $259; selected prescription and supply require confirmation. Payments ordinarily nonrefundable. Exact next-renewal cancellation deadline and unused-prepaid calculation unconfirmed; early exception has an unspecified fee. Full price detailsCompounded tirzepatide injection offered; complete selected-prescription quote unknown; three-month plan $549 upfront ($183/month equivalent), or monthly $259 after $199 first month |
| Coverage | US only; restrictions by state, confirmed at intake | Service depends on state/provider availability under the terms; complete current medication-specific state list unconfirmed |
| Brand-name access | Not confirmed | Brand comparisons explain differences from compounds, not an established current branded prescribing program. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
NativeMed: Three-month prepay $447/$549; monthly renewal $179/$259 after $159/$199 first month. Refund request within 24 hours also requires no shipment and deducts an undisclosed administrative fee.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.